Nutritional recommendations for patients undergoing prolonged glucocorticoid therapy.
Gabriel Perri EstevesBruna Caruso MazzolaniFabiana Infante SmairaElizabeth Silva MendesGabriela Guimarães de OliveiraHamilton RoschelBruno GualanoRosa Maria Rodrigues PereiraEimear DolanPublished in: Rheumatology advances in practice (2022)
Glucocorticoid (GC) therapy is a common treatment used in rheumatic and autoimmune diseases, owing to its anti-inflammatory and immunosuppressive effects. However, GC therapy can also induce a number of adverse effects, including muscle and bone loss, hypertension, metabolic perturbations and increased visceral adiposity. We review available evidence in this area and provide nutritional recommendations that might ameliorate these adverse effects. Briefly, optimizing calcium, vitamin D, sodium and protein intake and increasing consumption of unprocessed and minimally processed foods, while decreasing the consumption of ultra-processed foods, might counteract some of the specific challenges faced by these patients. Importantly, we identify a dearth of empirical data on how nutritional intervention might impact health-related outcomes in this population. Further research is required to investigate the clinical and therapeutic efficacy of these theory-based recommendations.
Keyphrases
- patients undergoing
- bone loss
- clinical practice
- end stage renal disease
- anti inflammatory
- randomized controlled trial
- blood pressure
- ejection fraction
- insulin resistance
- newly diagnosed
- rheumatoid arthritis
- type diabetes
- high resolution
- weight gain
- electronic health record
- peritoneal dialysis
- patient reported outcomes
- mass spectrometry
- mesenchymal stem cells
- small molecule
- machine learning
- deep learning
- replacement therapy
- cell therapy
- data analysis
- gas chromatography
- simultaneous determination